SCHEMBL3046700

SCHEMBL3046700

CC(C)(C)OC(=O)n1c(-c2ccc(Cl)c3c2C(=O)NC3)cc2cc(CNCc3cccnc3)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTK P33981 1/20 0.38
NR1H2 P55055 9/20 0.36
NAMPT P43490 1/20 0.36
BRD4 O60885 1/20 0.35
CREBBP Q92793 1/20 0.35
CYP3A4 P08684 1/20 0.35
DPP4 P27487 1/20 0.35
KCNH2 Q12809 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DPP9 Q86TI2 1/20 0.35
KDM4E B2RXH2 1/20 0.35
NR1H3 Q13133 2/20 0.34
ALDH1A1 P00352 1/20 0.34
PDGFRB P09619 1/20 0.34
KDR P35968 1/20 0.34
PIM1 P11309 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
LMNA P02545 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3046618 0.95 NR1H2 (0.36) TTKNR1H2BRD4CREBBPNR1H3
SCHEMBL3051414 0.93 NR1H2 (0.37) TTKNR1H2NAMPTBRD4CREBBP
SCHEMBL3046659 0.92 NR1H2 (0.44) NR1H2BRD4CREBBPNR1H3
SCHEMBL3043856 0.91 NR1H2 (0.38) NR1H2BRD4CREBBPNR1H3PIM1
SCHEMBL3050351 0.89 NR1H2 (0.38) NR1H2BRD4CREBBPNR1H3KDR
SCHEMBL3050173 0.89 NR1H2 (0.37) NR1H2BRD4CREBBPNR1H3
SCHEMBL3047044 0.88 NR1H2 (0.40) NR1H2BRD4CREBBPNR1H3
SCHEMBL3041523 0.88 NR1H2 (0.39) NR1H2BRD4CREBBPNR1H3ALDH1A1
SCHEMBL3053972 0.88 NR1H2 (0.38) NR1H2BRD4CREBBPNR1H3ALDH1A1
SCHEMBL3045004 0.87 NR1H2 (0.39) NR1H2BRD4CREBBPNR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1880993-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 TTK 3837/4885NR1H2 21/4885NAMPT 1354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.